Latest News on AIP

Financial News Based On Company


Advertisement
Advertisement

Form 144 ARTERIS INC For: 11 November By Investing.com

https://ca.investing.com/news/stock-market-news/form-144-arteris-inc-for-11-november-93CH-4949176
This article announces the filing of Form 144 for ARTERIS INC, related to transactions on November 11. Form 144 is a notice of the intent to sell restricted securities, indicating potential insider trading activity. The brief announcement provides no further details about the specific transactions or the individuals involved.

Form 144 ARTERIS INC For: 11 November By Investing.com

https://in.investing.com/news/stock-market-news/form-144-arteris-inc-for-11-november-93CH-5696189
The article reports the filing of Form 144 for Arteris Inc. on November 11. Form 144 is a notice of the intent to sell restricted securities, indicating that insiders or affiliates plan to sell company shares. The brief notice provides no further details on the specific transaction.

Have Arteris Insiders Been Selling Stock?

https://simplywall.st/stocks/us/software/nasdaq-aip/arteris/news/have-arteris-insiders-been-selling-stock-1
Arteris, Inc. (NASDAQ:AIP) recently saw its Chairman, Karel Janac, sell shares worth approximately US$1.8m, reducing his holding by 1.2%. While this was the largest insider sale in the past year, insiders still own a significant 18% of the company. However, the absence of insider buying in the last 12 months, coupled with recent selling, raises some concerns for investors.

Form 4 Arteris Inc: Wayne C. Cantwell (Director) For: 4 November By Investing.com

https://au.investing.com/news/stock-market-news/form-4-arteris-inc-wayne-c-cantwell-director-for-4-november-93CH-4753067
The article reports on a Form 4 filing for Arteris Inc., indicating a transaction by Director Wayne C. Cantwell on November 4th. This news is presented within a broader financial market context provided by Investing.com, alongside various market data and other news headlines. The specific details of the transaction are not provided in the snippet.

Form 4 Arteris Inc: Wayne C. Cantwell (Director) For: 4 November By Investing.com

https://ca.investing.com/news/stock-market-news/form-4-arteris-inc-wayne-c-cantwell-director-for-4-november-93CH-4940855
This article reports on a Form 4 filing for Arteris Inc., indicating a transaction by Director Wayne C. Cantwell on November 4. The brief report highlights the insider transaction for the company, Arteris Inc. (AIP), which saw an 11.74% increase.
Advertisement

Jefferies maintains Arteris at Buy, lowers price target to $40 from $50

https://www.tradingview.com/news/tradingview:97af354c0c8df:0-jefferies-maintains-arteris-at-buy-lowers-price-target-to-40-from-50/
Jefferies has reiterated its "Buy" rating for Arteris, though it has reduced the price target to $40 from $50. This new price target suggests a potential upside of 124.7% from the stock's closing price of $17.80 on November 6. Investors can find more detailed analyst data and ratings for Arteris on the Forecasts tab of TradingView.

Arteris 3Q 2026: Revenue $25.77M, EPS ($0.23) — 10-Q Summary

https://www.tradingview.com/news/tradingview:86442eb62172c:0-arteris-3q-2026-revenue-25-77m-eps-0-23-10-q-summary/
Arteris reported a significant increase in third-quarter revenue, up 48% year over year to $25.77M, driven by new license arrangements, customer additions, Cycuity hardware security products, and increased royalty revenue. Despite the revenue growth, the company's net loss widened to ($11.15M) from ($8.99M) in the prior year, resulting in a diluted EPS of ($0.23), primarily due to higher employee-related costs, R&D investments, and expenses following the Cycuity acquisition. Annual Contract Value also saw substantial growth, reaching $94.4M as of September 30, 2026.

Arteris Q3 Results: Loss narrows to $(0.02), revenue up 48%

https://scanx.trade/stock-market-news/companies/arteris-q3-results-loss-narrows-0-02-revenue-up-48/55459374
Arteris Inc. reported a significant improvement in its Q3 FY26 financial results, with revenue soaring 48% year-over-year to $25.8 million, surpassing analyst estimates. The company also narrowed its adjusted loss per share to $(0.02), beating expectations by 50%. Following this strong performance, Arteris raised its full-year FY26 revenue guidance to $98.5-$99.5 million, reflecting increased confidence in future growth.

Arteris Q3 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/11/62958234/arteris-q3-2026-earnings-call-transcript
Arteris reported record Q3 2026 financial results, including $104 million in annual contract value plus royalties and $25.8 million in revenue, driven by strong license activity in AI infrastructure and physical AI. The company also announced an expansion of its chiplet and multi-die solution and raised its full-year 2026 guidance, expecting continued growth and improved operating leverage. Saurabh Sinha joined as the new CFO, emphasizing a commitment to growing operating expenses at half the rate of revenue growth.

Arteris Announces Financial Results for the Third Quarter and Estimated Fourth Quarter and Updated Full Year 2026 Guidance

https://www.manilatimes.net/2026/11/06/tmt-newswire/globenewswire/arteris-announces-financial-results-for-the-third-quarter-and-estimated-fourth-quarter-and-updated-full-year-2026-guidance/2463489
Arteris, Inc. announced strong financial results for the third quarter of 2026, including record revenue of $25.8 million, up 48% year-over-year, and Annual Contract Value plus royalties of $103.8 million, up 39% year-over-year. The company reported continued strong customer design activity, particularly in AI infrastructure and edge computing, and expanded its multi-die solutions. Arteris also provided estimated fourth quarter and updated full year 2026 guidance, expecting revenue between $98.5 million and $99.5 million for the full year.
Advertisement

Arteris Surpasses 1,000 Customer Design Starts, Highlighting the Evolution of Semiconductor Design

https://www.manilatimes.net/2026/11/05/tmt-newswire/globenewswire/arteris-surpasses-1000-customer-design-starts-highlighting-the-evolution-of-semiconductor-design/2463083
Arteris, Inc. announced it has surpassed 1,000 customer silicon design starts using its interconnect IP, marking a significant milestone in semiconductor innovation. The company released a report, "The State of Semiconductor Innovation: Insights from 1,000 Design Starts," highlighting key trends such as the exponential growth of AI-related designs, the increasing autonomy of physical AI systems, and the quadrupling of enterprise computing's share in design activity. This achievement underscores the critical role of efficient data movement and optimized silicon architectures in the AI era.

Form 4 Arteris Inc: K. Charles Janac (Director, 10% Owner, President and CEO) For: 2 November

https://ca.investing.com/news/stock-market-news/form-4-arteris-inc-k-charles-janac-director-10-owner-president-and-ceo-for-2-november-93CH-4933583
This article reports on a Form 4 filing for Arteris Inc., detailing that K. Charles Janac, identified as a Director, 10% Owner, President, and CEO, made a transaction on November 2nd. The brief mention indicates an insider transaction without providing further specifics about the nature or value of the transaction.

Form 4 Arteris Inc: K. Charles Janac (Director, 10% Owner, President and CEO) For: 2 November

https://uk.investing.com/news/stock-market-news/form-4-arteris-inc-k-charles-janac-director-10-owner-president-and-ceo-for-2-november-93CH-4959970
This article reports on a Form 4 filing for Arteris Inc., indicating that K. Charles Janac, who serves as a Director, 10% Owner, President, and CEO, made a transaction on November 2nd. Form 4 filings are used to disclose changes in beneficial ownership of a company's securities by insiders.

A 10% owner sells 95,099 and 4,901 Arteris (AIP) shares under a prearranged trading plan.

https://www.stocktitan.net/sec-filings/AIP/form-4-arteris-inc-insider-trading-activity-2ae3ef4ef82c.html
Bayview Legacy, a 10% owner of Arteris, Inc. (AIP), sold a total of 100,000 shares on November 2, 2026, under a Rule 10b5-1 trading plan. The shares were sold in two separate transactions at weighted average prices of $18.1856 for 95,099 shares and $18.8147 for 4,901 shares. K. Charles Janac, Bayview Legacy's manager, is deemed to have voting and dispositive power over these shares.

CEO-managed Bayview Legacy sells 95,099 and 4,901 Arteris (AIP) shares under a trading plan.

https://www.stocktitan.net/sec-filings/AIP/form-4-arteris-inc-insider-trading-activity-e8117e580557.html
Bayview Legacy, LLC, managed by Arteris (AIP) President and CEO K. Charles Janac, sold a total of 100,000 shares of Arteris common stock in two tranches on November 2, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025. Following these transactions, Janac's direct holdings and those held by the Charles and Lydia Janac Trust were updated.
Advertisement

Earnings Preview: Arteris to Report Financial Results Post-market on November 05

https://www.moomoo.com/news/post/1003075325/earnings-preview-arteris-to-report-financial-results-post-market-on
Arteris (NASDAQ: AIP) is scheduled to report its financial results after the market closes on November 5. Analysts anticipate the company to post earnings of $-0.10 per share and revenue of $14.17 million for the upcoming report. Investors will be keen to see if Arteris meets or exceeds these expectations.

InvestingPro’s Fair Value spotted Arteris overvaluation before 52% drop By Investing.com

https://www.investing.com/news/investment-ideas/investingpros-fair-value-spotted-arteris-overvaluation-before-52-drop-93CH-4986912
InvestingPro’s Fair Value models accurately identified Arteris, Inc. (NASDAQ:AIP) as significantly overvalued in June 2026, when its stock was trading near an all-time high of $45.33, suggesting an intrinsic value closer to $22.84. This warning proved prescient as the stock subsequently plummeted by 52% to $20.59 by late October 2026, validating the precision of the Fair Value assessment despite positive industry sentiment and analyst upgrades. The article highlights how InvestingPro's methodology helps investors avoid overpriced securities by analyzing various valuation metrics and providing real-time alerts.

The EU Cyber Resilience Act Reaches Chip And IP Suppliers

https://semiengineering.com/the-eu-cyber-resilience-act-reaches-chip-and-ip-suppliers/
The EU Cyber Resilience Act (CRA), adopted in October 2024, now extends its mandatory cybersecurity requirements to chip and intellectual property (IP) suppliers, regardless of their location. The CRA's mandatory reporting phase took effect in September 2026, requiring manufacturers to report vulnerabilities and incidents. This necessitates that component suppliers understand their obligations and provide security evidence to support customers' compliance.

Arteris, Inc. Estimates – BOATS:AIP

https://www.tradingview.com/symbols/BOATS-AIP/financials-estimates/
The article provides an overview of Arteris, Inc. (AIP) financial data and analyst estimates available on TradingView. It highlights features for exploring reported financial data across income statements, balance sheets, cash flow, and valuation metrics, allowing users to compare actual results with average, high, and low estimates. The content primarily serves as a guide for investors to analyze trends over time, while explicitly stating it is not investment advice.

AIP: Arteris Inc Latest Stock Price, Analysis, News and Trading Ideas

https://stocktwits.com/symbol/AIP
This article provides an overview of Arteris Inc. (AIP), including its latest stock price, financial fundamentals, and sentiment from investors. The company, which specializes in interconnect and other intellectual property technology for chip design, is highlighted as a key player in the shift towards heterogeneous chiplets. Investor commentary suggests that the market may be undervaluing AIP by treating it as a legacy software vendor rather than an essential IP compounder in the evolving custom silicon industry.
Advertisement

Arteris to Announce Financial Results for the Third Quarter 2026 on Thursday, November 5, 2026

https://www.manilatimes.net/2026/10/21/tmt-newswire/globenewswire/arteris-to-announce-financial-results-for-the-third-quarter-2026-on-thursday-november-5-2026/2450647
Arteris, Inc. announced that it will release its financial results for the third quarter ended September 30, 2026, after market close on Thursday, November 5, 2026. Management will host a conference call at 4:30 PM ET on the same day to discuss these results. A live webcast of the call will be available in the Investor Relations section of Arteris’ website.

Arteris Price Target Cut to $25.00/Share From $40.00 by TD Cowen

https://www.moomoo.com/news/post/1001701125/arteris-price-target-cut-to-25-00-share-from-40
TD Cowen has reduced its price target for Arteris (NASDAQ: AIP) shares from $40.00 to $25.00, while maintaining a "Buy" rating on the stock. This adjustment reflects a change in the firm's valuation, though the positive outlook on the company remains.

Arteris to Announce Financial Results for the Third Quarter 2026 on Thursday, November 5, 2026

https://www.manilatimes.net/2026/10/21/tmt-newswire/globenewswire/arteris-to-announce-financial-results-for-the-third-quarter-2026-on-thursday-november-5-2026/2450647/amp
Arteris, Inc. (Nasdaq: AIP) announced it will release its financial results for the third quarter ended September 30, 2026, after market close on Thursday, November 5, 2026. Management will host a conference call on the same day at 4:30 PM ET to discuss these results, with a live webcast available on their investor relations website. A replay of the webcast will also be available for approximately 30 days after the call.

Price to sales forward of Arteris, Inc. – MUN:3CN

https://www.tradingview.com/symbols/MUN-3CN/financials-statistics-and-ratios/price-sales-fwd/
This article provides a brief snapshot of the "Price to sales forward" metric for Arteris, Inc. (MUN:3CN) on the Munich Stock Exchange. It indicates that the market was closed with no trades at the time of publication and offers financial data. The content is primarily a data point from TradingView without further analysis.

Arteris Q2 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/10/62297253/arteris-q2-2026-earnings-call-transcript
Arteris Inc. reported record-breaking results for Q2 2026, with annual contract value (ACV) plus royalties reaching $99.5 million, a 44% year-over-year increase, and revenue hitting $24.1 million, up 46%. The company raised its full-year 2026 revenue guidance to $95-$98 million, reflecting strong market conditions, particularly in enterprise computing and automotive sectors. Nick Hawkins, the outgoing CFO, announced the successful completion of an ATM program raising $72 million and confirmed non-GAAP profitability is expected by the end of 2026, with Saurabh Sinha taking over as CFO in September 2026.
Advertisement

Form 144 Arteris For: 12 October By Investing.com

https://ng.investing.com/news/stock-market-news/form-144-arteris-for-12-october-93CH-2730952
The article, titled "Form 144 Arteris For: 12 October," is a brief announcement from Investing.com. It indicates that a Form 144 filing related to Arteris was made on October 12, 2026. The content provides no further details about the filing itself but is surrounded by extensive navigation and market data from the Investing.com platform.

Form 144 Arteris For: 12 October By Investing.com

https://za.investing.com/news/stock-market-news/form-144-arteris-for-12-october-93CH-4499169
This article announces the filing of Form 144 for Arteris on October 12, 2026, as reported by Investing.com. It is a brief, one-sentence news update. The article provides no further details beyond the title and date of the filing.

Form 144 Arteris For: 12 October By Investing.com

https://ca.investing.com/news/stock-market-news/form-144-arteris-for-12-october-93CH-4875305
This article from Investing.com reports on a Form 144 filing for Arteris on October 12, 2026. The content is brief, primarily serving as a notice of the filing with minimal additional detail. It also includes general market data and related news headlines.

Arteris (AIP) Dropped, So What Is Behind the Latest Attention?

https://simplywall.st/stocks/us/software/nasdaq-aip/arteris/news/arteris-aip-dropped-so-what-is-behind-the-latest-attention
Arteris (AIP) has seen increased investor attention following the expansion of its third-party IP security assurance program with BAE Systems and SiFive, backed by US$3.3 million in government funding. Despite a recent drop, the stock shows strong long-term momentum and is considered 44% undervalued by many, with a fair value of $41. However, the company faces challenges with ongoing losses and a high P/S ratio compared to industry averages, suggesting it might be expensive on sales multiples.

3CN | Arteris Inc. Stock Overview (Germany: Frankfurt)

https://www.barrons.com/market-data/stocks/3CN?countrycode=DE
This article provides an overview of Arteris Inc. (3CN) stock performance on the Frankfurt exchange, including its current market data, analyst ratings, key executives, major holders, and financial statements. The company's stock is currently trading at €0.00 with a market value of €1.03 billion, and analysts have an average price target of €39.43. Arteris Inc. specializes in interconnect and intellectual property technology for semiconductors.
Advertisement

Arteris Gets Funding to Expand Third-Party IP Security Assurance Program

https://finance.yahoo.com/technology/ai/articles/arteris-gets-funding-expand-third-143907503.html
Arteris (AIP) announced that it is expanding its third-party IP security assurance program. This expansion is being undertaken in collaboration with undisclosed partners. The full details of the initiative are available to subscribers of premium news services.

A $3.3 million effort aims to make chip security checks repeatable for defense systems.

https://www.stocktitan.net/news/AIP/arteris-wins-funding-to-expand-hardware-design-supply-chain-security-8etkl7olvtcs.html
Arteris (AIP) has secured an additional $3.3 million in funding through the government's Trusted and Assured Microelectronics program to expand its chip-design security assurance initiative. Collaborating with BAE Systems and SiFive, the program focuses on enhancing the security of commercially sourced chip-design intellectual property used in critical aerospace and defense applications. The primary goal is to develop a repeatable, evidence-based methodology for verifying the secure implementation and integration of these components within systems-on-chip.

Form 4 Arteris Inc For: 6 October By Investing.com

https://ng.investing.com/news/stock-market-news/form-4-arteris-inc-for-6-october-93CH-2724368
This article reports on a Form 4 filing for Arteris Inc. on October 6. Form 4 filings are legally required documents by the U.S. Securities and Exchange Commission that disclose changes in the beneficial ownership of a company's stock by insiders. The article provides no further details about the specific transactions.

Form 4 Arteris Inc For: 6 October By Investing.com

https://uk.investing.com/news/stock-market-news/form-4-arteris-inc-for-6-october-93CH-4898063
The article reports on a Form 4 filing by Arteris Inc. for October 6th. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in their ownership of the company's stock. The article provides minimal detail beyond the filing's existence.

Form 4 Arteris, Inc. For: Oct 05 Filed by: Alpern Paul L

https://www.streetinsider.com/SEC+Filings/Form+4+Arteris,+Inc.+For:+Oct+05+Filed+by:+Alpern+Paul+L/27155722.html
Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), filed a Form 4 indicating the sale of 6,003 shares of common stock on October 5, 2026, at a weighted average price of $24.2379. This transaction was conducted under a 10b5-1 trading plan adopted in February 2026, leaving Alpern with 61,082 beneficially owned shares.
Advertisement

Arteris Director Joachim Kunkel Acquires 633 Shares as Retainer Compensation

https://kalkinemedia.com/us/news/announcements/arteris-director-joachim-kunkel-acquires-633-shares-as-retainer-compensation
Arteris, Inc. director Joachim Kunkel acquired 633 shares of the company's common stock on October 5, 2026. These shares were received as retainer compensation, opted for in lieu of cash. Following this transaction, Kunkel directly holds 75,328 shares of Arteris.

Arteris Wins Funding to Expand Hardware Design Supply Chain Security Assurance for the Trusted and Assured Microelectronics Program

https://www.manilatimes.net/2026/10/06/tmt-newswire/globenewswire/arteris-wins-funding-to-expand-hardware-design-supply-chain-security-assurance-for-the-trusted-and-assured-microelectronics-program/2440063/amp
Arteris, in collaboration with BAE Systems and SiFive, has secured an additional $3.3 million in funding for its third-party IP (3PIP) security assurance program through the Trusted and Assured Microelectronics (T&AM) program. This initiative aims to enhance the security and trustworthiness of commercially sourced third-party silicon IP integrated into advanced systems-on-chip (SoCs), particularly for mission-critical aerospace and defense systems. The program will establish a repeatable, evidence-based methodology for evaluating and verifying the secure implementation and integration of third-party IP, supporting broader industry and government efforts to strengthen semiconductor design supply chain security.

A proposed sale covers 2,003 Arteris (NASDAQ: AIP) shares held by officer Paul Alpern.

https://www.stocktitan.net/sec-filings/AIP/144-arteris-inc-sec-filing-b43e59910f3b.html
Arteris, Inc. officer Paul Alpern has filed a Form 144 to propose selling 2,003 common shares of the company, valued at approximately $49,393.98. The proposed sale has an approximate date of October 5, 2026, and Morgan Stanley Smith Barney LLC is listed as the broker. This filing indicates 49,152,102 shares outstanding for Arteris.

K. Charles Janac proposes selling 11,452 common shares of Arteris (AIP).

https://www.stocktitan.net/sec-filings/AIP/144-arteris-inc-sec-filing-ebc6c8105b9a.html
K. Charles Janac, associated with Arteris, Inc. (AIP), has proposed selling 11,452 common shares, valued at approximately $282,406.32, with an anticipated sale date of October 5, 2026. This proposed sale is being handled by Morgan Stanley Smith Barney LLC. The SEC filing also details prior 10b5-1 sales by Bayview Legacy, LLC and K. Charles Janac between July and October 2026.

After selling 9,219 shares, Arteris (AIP) officer Laurent Moll proposes another sale.

https://www.stocktitan.net/sec-filings/AIP/144-arteris-inc-sec-filing-a1df9c918f9f.html
Arteris, Inc. (AIP) officer Laurent Moll has proposed the sale of 32,713 common shares, valued at approximately $806,702.58, with an anticipated sale date of October 5, 2026. This follows a prior sale of 9,219 shares on September 14, 2026, for $192,222.60. The shares intended for sale are associated with an Employee Stock Purchase Plan and Restricted Stock Units, acquired between April 1, 2024, and October 1, 2026.
Advertisement

After a $2.07M September sale, a 10% holder proposes selling more Arteris (AIP) shares.

https://www.stocktitan.net/sec-filings/AIP/144-arteris-inc-sec-filing-b5061eae9668.html
Bayview Legacy, a 10% stockholder of Arteris, Inc. (AIP), has proposed to sell 300,000 shares of common stock with an aggregate market value of $7.09 million. This proposed sale follows previous transactions, including a $2.07 million sale of 100,000 shares on September 1, 2026. The shares were originally acquired through a private acquisition from the issuer in November 2013.

Form 144 | Arteris(AIP.US) 10% Stockholder Proposes to Sell 7.09 Million in Common Stocks

https://www.moomoo.com/news/flash/1000527180/form-144-arteris-aipus-10-stockholder-proposes-to-sell-7
A 10% stockholder of Arteris (AIP.US) has filed a Form 144 proposing to sell 7.09 million common stocks. This regulatory filing indicates a significant potential stock sale by a major shareholder, which could be of interest to investors tracking insider activity and stock movements for Arteris.

Form 144 ARTERIS INC For: 1 October By Investing.com

https://za.investing.com/news/stock-market-news/form-144-arteris-inc-for-1-october-93CH-4487262
This article from Investing.com announces the filing of Form 144 for ARTERIS INC, specifically referencing the date of October 1st. The brief entry reiterates the core information twice and includes a standard disclaimer from Reuters.

Form 144 ARTERIS INC For: 1 October By Investing.com

https://uk.investing.com/news/stock-market-news/form-144-arteris-inc-for-1-october-93CH-4892515
This article from Investing.com announces the filing of Form 144 for ARTERIS INC on October 1st. Form 144 is typically filed with the SEC when an insider intends to sell restricted or controlled securities. The brief notice provides no further details beyond the company, form type, and date.

AIP Should I Buy

https://intellectia.ai/en/stock/AIP/should-i-buy
Arteris Inc (AIP) is currently rated as a "Good Buy" with a price of $23.89, showing a year-to-date change of +53.34% and a bullish RSI of 60.24. Analysts from Craig-Hallum and Jefferies have set price targets of $30 and $50, respectively, indicating significant potential upside despite a reported net loss of -14,065,000 USD in Q2 2026. The positive outlook is driven by analyst upgrades and confidence in future profitability from automotive and AI programs, while the negative net income remains a key risk.
Advertisement

Craig-Hallum Initiates Arteris(AIP.US) With Buy Rating, Announces Target Price $30

https://www.moomoo.com/news/post/76538291/craig-hallum-initiates-arteris-aipus-with-buy-rating-announces-target
Craig-Hallum has initiated coverage on Arteris (AIP.US) with a Buy rating. The firm has set a target price of $30 for the company's stock.

Arteris Expands Multi-Die Chiplet-Based Portfolio

https://embeddedcomputing.com/technology/processing/chips-and-socs/arteris-expands-multi-die-chiplet-based-portfolio-2
Arteris, Inc. has expanded its multi-die portfolio with the new FlexGen Multi-Die product, designed to help semiconductor companies transition from monolithic SoC designs to chiplet-based architectures for AI, HPC, and consumer electronics. This expansion, along with Ncore Multi-Die, Magillem integration automation, and Cycuity hardware security assurance, aims to provide comprehensive solutions for complex multi-die designs. The company emphasizes preserving architectural intelligence across multiple dies and improving design reuse while reducing integration complexity.

A Look at Arteris Inc (AIP) After 7.1% Gain -- GF Value $10.95 v

https://www.gurufocus.com/news/9087195/a-look-at-arteris-inc-aip-after-71-gain-gf-value-1095-vs-price-2235
Arteris Inc (AIP) shares recently gained 7.1% but are considered significantly overvalued by GuruFocus, trading at $22.35 against a GF Value™ of $10.95. The company has a GF Score™ of 59/100, with strong growth but poor profitability and valuation. While some gurus are increasing their positions, significant insider selling raises concerns about the stock's future.

Arteris (AIP) executive lines up another stock sale

https://www.stocktitan.net/sec-filings/AIP/144-arteris-inc-sec-filing-1b781b00274f.html
Arteris, Inc. (AIP) officer Laurent Moll has filed a Form 144 notice to sell 12,219 shares of common stock through Morgan Stanley Smith Barney, valued at $277,249.11 as of September 14, 2026. This planned sale includes shares from Restricted Stock Units and an Employee Stock Purchase Plan, following previous sales by Moll in June and July 2026. The filing indicates a neutral impact and sentiment according to Rhea-AI.

Arteris Expands Multi-Die Portfolio With FlexGen Multi-Die for AI, HPC and Chiplet-Based Architectures

https://www.quiverquant.com/news/Arteris+Expands+Multi-Die+Portfolio+With+FlexGen+Multi-Die+for+AI%2C+HPC+and+Chiplet-Based+Architectures
Arteris, Inc. has expanded its multi-die portfolio with the new FlexGen Multi-Die product, designed to help semiconductor companies transition from monolithic system-on-chip designs to chiplet-based architectures. This innovation specifically targets AI, high-performance computing (HPC), and consumer electronics, addressing the challenges of data communication across chip boundaries. The FlexGen Multi-Die product extends network-on-chip (NoC) connectivity transparently across die-to-die links, aiming to simplify integration, maintain performance, and accelerate development for complex multi-die systems.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement